Short-term CD4+ cell count declines during antiretroviral therapy interruptions: a focused review.
Moolla H, Meintjes G, Davies MA, Kassanjee R, de Waal R, Johnson LF.
Journal of Acquired Immune Deficiency Syndrome. 2025; 10-97.
https://journals.lww.com/jaids/fulltext/2025/11010/short_term_cd4__cell_count_declines_during.13.aspx
Identifying gaps in the HIV treatment cascade in Africa: a model comparison study.
Bansi-Matharu L, Moolla H, Citron DT, Stover J, Pickles M, Martin-Hughes R, Boily M-C, Nyirenda R, Mudimu E, ten Brink D, Johnson LF, Mugurungi O, Cambiano V, Dimitrov D, Smith J, Glaubius R, Taramusi I, Mpofu A, Phillips A, Bershteyn A.
The Lancet Global Health. 2025; 13(6):e1006-e1019.
https://www.sciencedirect.com/science/article/pii/S2214109X25001214
The HIV response beyond 2030: preparing for decades of sustained HIV epidemic control in eastern and southern Africa.
The Post-2030 HIV Response Working Group.
The Lancet. 2024; 404(10453):638-41.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00980-2/fulltext
The effect of care interruptions on mortality in adults resuming antiretroviral therapy.
Moolla H, Davies MA, Davies C, Euvrard J, Prozesky HW, Fox MP, Orrell C, Von Groote P, Johnson LF.
AIDS. 2024; 38(8):1198-205.
A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa: a model comparison study.
Moolla H, Phillips A, ten Brink D, Mudimu E, Stover J, Bansi-Matharu L, Martin-Hughes R, Wulan N, Cambiano V, Smith J, Bershteyn A, Meyer-Rath G, Jamieson L and Johnson LF.
BMC Public Health. 2023; 23:2119.
https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-16995-9
Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma.
Robinson L, Smit C, van Heerden MB, Moolla H, Afrogheh AH, Opperman JF, Ambele MA, van Heerden WF.
Head and Neck Pathology. 2024; 18(1):92.
https://link.springer.com/article/10.1007/s12105-024-01704-8
ART history prior to conception: trends and association with postpartum disengagement from HIV care in Khayelitsha, South Africa (2013-2019): a retrospective cohort study.
Phillips TK, Kassanjee R, Maxwell N, Anderson K, Johnson L, Moolla H, Myer L, Chi BH, Euvrard J, Boulle A, Davies MA, Cornell M, de Waal R.
Journal of the International AIDS Society. 2024; 27(4):e26236.
https://onlinelibrary.wiley.com/doi/10.1002/jia2.26236
The use of C‐reactive protein to predict uncomplicated appendicitis and increase uptake of laparoscopy in low resource hospitals—A retrospective cohort study.
Brombacher M, Moolla H, Nair V, Clarke D.
World Journal of Surgery. 2024; 48(6):1515-20.
https://onlinelibrary.wiley.com/doi/10.1002/wjs.12202
Describing the end of AIDS as a public health threat.
Joint United Nations Programme on HIV/AIDS (UNAIDS). 2023. Geneva: Switzerland.
https://jointsiwg.unaids.org/publication/describing-the-end-of-aids-as-a-public-health-threat/
A tale of two waves: Characteristics and outcomes of COVID-19 admissions during the omicron-driven 4th wave in Cape Town, South Africa and implications for the future.
Moolla MS, Maponga T, Moolla H, Kollenberg E, Anie S, Moolla A, Moodley D, Lalla U, Allwood BW, Schrueder N, Preiser W.
IJID Regions. 2022; 6(2023):42-7.
https://www.sciencedirect.com/science/article/pii/S2772707622001412?via%3Dihub
A multi-state model of treatment states in an antiretroviral treatment programme cohort in Cape Town.
Moolla H. MPH dissertation, University of Cape Town. 2022. OpenUCT repository.
http://hdl.handle.net/11427/36601
MicroCOSM: a model of social and structural drivers of HIV and interventions to reduce HIV incidence in high-risk populations in South Africa.
Johnson LF, Kubjane M, Moolla H.
BioRxiv. 2018; 310763.
https://www.biorxiv.org/content/10.1101/310763v1.full
HIV epidemic drivers in South Africa: A model-based evaluation of factors accounting for inter-provincial differences in HIV prevalence and incidence trends.
Johnson LF, Dorrington RE, Moolla H.
Southern African Journal of HIV medicine. 2017; 18(1):a695.
https://www.ajol.info/index.php/sajhivm/article/download/161464/151031
Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa.
Johnson LF, Dorrington RE, Moolla H.
Southern African Journal of HIV medicine. 2017; 18(1):1-8.
https://www.ajol.info/index.php/sajhivm/article/download/161463/151030
A mathematical model evaluating the timing of early diagnostic testing in HIV-exposed infants in South Africa.
Lilian RR, Johnson LF, Moolla H, Sherman GG.
JAIDS Journal of Acquired Immune Deficiency Syndromes. 2014; 67(3):341-8.
Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?
Johnson LF, Estill J, Keiser O, Cornell M, Moolla H, Schomaker M, Grimsrud A, Davies MA, Boulle A.
American Journal of Epidemiology. 2014; 180(12):1208-12.
https://academic.oup.com/aje/article/180/12/1208/2739213